Australia - English - APVMA (Australian Pesticides and Veterinary Medicines Authority)

elanco australasia pty ltd - trimethoprim; sulfadiazine - oral tablet - trimethoprim pyrimidine active 20.0 mg/tb; sulfadiazine sulfanyl active 100.0 mg/tb - nutrition & metabolism - cat | dog - small or toy | cat - queen | cat - tom | dog - small | dog - toy | kitten - bacterial infection | infections of the alimentary tract | infections of the respiratory tract | infections of the urogenital tract | acute respiratory infections | amoxycillin sensitive bacteria | associated with viral disease | bronchiseptica | bronchitis | cystitis | gram negative organisms | gram positive organisms | metritis | nephritis | pharyngitis | pneumonia | post parturient bacterial infe | primary bacterial infection | sulfadiazine sensitive bacteri | tonsillitis | trimethoprim sensitive bacteri | tylosin sensitive bacteria

Australia - English - APVMA (Australian Pesticides and Veterinary Medicines Authority)

ccd animal health pty ltd - trimethoprim; sulfadiazine - oral powder, pre-mix - trimethoprim pyrimidine active 40.0 g/kg; sulfadiazine sulfanyl active 200.0 g/kg - antibiotic & related - calf | cattle | pigs | poultry | beef | beef calf | boar | bos indicus | bos taurus | bovine | breeders | broiler | buffalo | bu - bacterial overgrowth (staphylococcal) | escherichia coli (e. coli) | haemophilus spp. | infections of the alimentary tract | infections of the respiratory tract | organisms sensitive to combination of | organisms sensitive to sulphadiazine | organisms sensitive to trimethoprim | pasteurella spp. | salmonella | acute respiratory infections | bronchiseptica | bronchitis | haemophilus agni | haemophilus bovis | haemophilus parainfluenzae | haemophilus parasuis | haemophilus pleuropneumoniae | haemophilus somnus | haemophilus suis | including b-lactamase producin | pasterellosis | pasteurellosis | pharyngitis | pneumonia | salmonellosis | tonsillitis

Australia - English - APVMA (Australian Pesticides and Veterinary Medicines Authority)

ceva animal health pty ltd - bromhexine hydrochloride; trimethoprim; sulfadiazine - oral powder, pre-mix - bromhexine hydrochloride guanidine active 5.5 mg/g; trimethoprim pyrimidine active 130.0 mg/g; sulfadiazine sulfanyl active 650.0 mg/g - antibiotic & related - horse | colt | donkey | endurance horse | filly | foal | gelding | high performance horses | horses at stud | mare | pacer | pol - antibiotics - oral, parenteral | airsacculitis | amoxycillin sensitive bacteria | anaerobic bacterial infection | avian mycoplasmas | clavulanic acid sensitive | coccidiosis | coryza | crd | dermatoses | diarrhoea | endometritis | enteritis | enzootic pneumonia | escherichia coli | european brood disease | gentamicin sensitive | hypermotility | infected wounds | infections | lactating | mastitis | protozoal infections | pyometra | salmonellosis | sinusitis | systemic bacterial infection

Australia - English - APVMA (Australian Pesticides and Veterinary Medicines Authority)

intervet australia pty limited - trimethoprim; sulfadiazine - oral bolus + intra vaginal/uterine - trimethoprim pyrimidine active 200.0 mg/pb; sulfadiazine sulfanyl active 1000.0 mg/pb - antibiotic & related - cattle | horse | pigs | sheep | beef | boar | bos indicus | bos taurus | bovine | buffalo | bull | bullock | calf | colt | cow | - bacterial infection | amoxycillin sensitive bacteria | associated with viral disease | gram negative organisms | gram positive organisms | post parturient bacterial infe | primary bacterial infection | sulfadiazine sensitive bacteri | trimethoprim sensitive bacteri | tylosin sensitive bacteria

Australia - English - APVMA (Australian Pesticides and Veterinary Medicines Authority)

intervet australia pty limited - trimethoprim; sulfadiazine - parenteral liquid/solution/suspension - trimethoprim pyrimidine active 80.0 mg/ml; sulfadiazine sulfanyl active 400.0 mg/ml - antibiotic & related - cattle | horse | pigs | sheep ewe - dry | beef | boar | bos indicus | bos taurus | bovine | buffalo | bull | bullock | calf | co - bacterial infection | infections of the alimentary tract | infections of the respiratory tract | infections of the urogenital tract | acute respiratory infections | amoxycillin sensitive bacteria | associated with viral disease | bronchiseptica | bronchitis | cystitis | gram negative organisms | gram positive organisms | metritis | nephritis | pharyngitis | pneumonia | post parturient bacterial infe | primary bacterial infection | sulfadiazine sensitive bacteri | tonsillitis | trimethoprim sensitive bacteri | tylosin sensitive bacteria

New Zealand - English - Medsafe (Medicines Safety Authority)

glaxosmithkline nz limited - trimethoprim - tablet - 100mg, 300mg - active: trimethoprim

United States - English - NLM (National Library of Medicine)

neogen corporation - trimethoprim (unii: an164j8y0x) (trimethoprim - unii:an164j8y0x), sulfadiazine (unii: 0n7609k889) (sulfadiazine - unii:0n7609k889) - trimethoprim 67 mg in 1 g - uniprim powder for horses is indicated in horses where potent systemic antibacterial action against sensitive organisms is required. uniprim powder for horses is indicated where control of bacterial infections is required during treatment of: uniprim powder for horses is well tolerated by foals. trimethoprim and sulfadiazine should not be used in horses showing marked liver parenchymal damage, blood dyscrasias, or in those with history of sulfonamide sensitivity.

Australia - English - Department of Health (Therapeutic Goods Administration)

pfizer australia pty ltd - trimethoprim, quantity: 16 mg/ml; sulfamethoxazole, quantity: 80 mg/ml - injection, concentrated - excipient ingredients: sodium metabisulfite; propylene glycol; ethanol; diethanolamine; sodium hydroxide; water for injections; hydrochloric acid - indications as at 31 october 2003 :parenteral administration of sulfamethoxazole/trimethoprim is indicated where oral dosage is not desirable or practical, e.g. pre- and post-operative infections associated with surgery, trauma or gynaecology; septicaemia and other infections due to sensitive organisms such as typhoid and paratyphoid.

United States - English - NLM (National Library of Medicine)

bryant ranch prepack - trimethoprim (unii: an164j8y0x) (trimethoprim - unii:an164j8y0x) - to reduce the development of drug-resistant bacteria and maintain the effectiveness of trimethoprim tablets, usp and other antibacterial drugs, trimethoprim tablets, usp should be used only to treat or prevent infections that are proven or strongly suspected to be caused by susceptible bacteria. when culture and susceptibility information are available, they should be considered in selecting or modifying antibacterial therapy. in the absence of such data, local epidemiology and susceptibility patterns may contribute to the empiric selection of therapy. for the treatment of initial episodes of uncomplicated urinary tract infections due to susceptible strains of the following organisms: escherichia coli , proteus mirabilis , klebsiella pneumoniae , enterobacter species, and coagulase-negative staphylococcus species, including s. saprophyticus . cultures and susceptibility tests should be performed to determine the susceptibility of the bacteria to trimethoprim. therapy may be initiated prior to obtaining the

United States - English - NLM (National Library of Medicine)

direct_rx - trimethoprim sulfate (unii: e377mf8eq8) (trimethoprim - unii:an164j8y0x), polymyxin b sulfate (unii: 19371312d4) (polymyxin b - unii:j2vz07j96k) - trimethoprim sulfate and polymyxin b sulfate ophthalmic solution is indicated in the treatment of surface ocular bacterial infections, including acute bacterial conjunctivitis, and blepharoconjunctivitis, caused by susceptible strains of the following microorganisms: staphylococcus aureus, staphylococcus epidermidis, streptococcus pneumoniae, streptococcus viridans, haemophilus influenza and pseudomonas aeruginosa.* *efficacy for this organism in this organ system was studied in fewer than 10 infections. trimethoprim sulfate and polymyxin b sulfate ophthalmic solution is contraindicated in patients with known hypersensitivity to any of its components.